PAM
PVG Asset Management Portfolio holdings
AUM
$23M
This Quarter Return
+5.46%
1 Year Return
+3.57%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$21.1M
AUM Growth
+$21.1M
(-15%)
Cap. Flow
-$3.77M
Cap. Flow
% of AUM
-17.84%
Top 10 Holdings %
Top 10 Hldgs %
42.97%
Holding
72
New
28
Increased
7
Reduced
10
Closed
26
Top Buys
| 1 |
Nuveen S&P 500 Buy-Write Income Fund
BXMX
|
$1.28M |
| 2 |
ProShares Short S&P500
SH
|
$1.05M |
| 3 |
NVIDIA
NVDA
|
$834K |
| 4 |
Amazon
AMZN
|
$743K |
| 5 |
Anavex Life Sciences
AVXL
|
$703K |
Top Sells
| 1 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
$3.73M |
| 2 |
ProShares UltraShort S&P500
SDS
|
$2.91M |
| 3 |
APA Corp
APA
|
$757K |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
$755K |
| 5 |
Macy's
M
|
$730K |
Sector Composition
| 1 | Healthcare | 30.35% |
| 2 | Technology | 15.47% |
| 3 | Consumer Discretionary | 4.64% |
| 4 | Real Estate | 4.4% |
| 5 | Consumer Staples | 4.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Nuveen S&P 500 Buy-Write Income Fund
BXMX
$1.48B
| $1.28M | 6.05% | +91,460 | New | +$1.28M |
|
2
Vanguard S&P 500 ETF
VOO
$726B
| $1.2M | 5.67% | 2,226 -288 | -11% | -$155K |
|
|
3
ProShares Short S&P500
SH
$1.25B
| $1.05M | 4.98% | +24,859 | New | +$1.05M |
|
4
iShares Core S&P 500 ETF
IVV
$662B
| $994K | 4.7% | 1,688 -183 | -10% | -$108K |
|
|
5
Anavex Life Sciences
AVXL
$828M
| $843K | 3.99% | 78,490 +65,485 | +504% | +$703K |
|
|
6
NVIDIA
NVDA
$4.24T
| $834K | 3.94% | +6,207 | New | +$834K |
|
7
Fortress Biotech
FBIO
$76.8M
| $782K | 3.7% | 386,295 +12,505 | +3% | +$25.3K |
|
|
8
Amazon
AMZN
$2.44T
| $743K | 3.51% | +3,386 | New | +$743K |
|
9
Veru
VERU
$47.6M
| $681K | 3.22% | 1,047,310 +410,340 | +64% | +$267K |
|
10
Pfizer
PFE
$141B
| $673K | 3.19% | +25,379 | New | +$673K |
|
11
Apple
AAPL
$3.45T
| $672K | 3.18% | +2,685 | New | +$672K |
|
12
Journey Medical
DERM
$176M
| $657K | 3.11% | 168,105 +560 | +0.3% | +$2.19K |
|
|
CRDL
13
Cardiol Therapeutics
CRDL
$90.4M
| $624K | 2.95% | +487,295 | New | +$624K |
|
14
iShares Russell 2000 ETF
IWM
$67B
| $568K | 2.69% | 2,571 +939 | +58% | +$207K |
|
|
15
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$42.1B
| $547K | 2.59% | 5,982 -40,743 | -87% | -$3.73M |
|
16
Microsoft
MSFT
$3.77T
| $542K | 2.56% | +1,286 | New | +$542K |
|
17
Broadcom
AVGO
$1.4T
| $540K | 2.56% | +2,330 | New | +$540K |
|
|
18
ProShares UltraShort S&P500
SDS
$445M
| $501K | 2.37% | 25,458 -148,129 | -85% | -$2.91M |
|
|
DX
19
Dynex Capital
DX
$1.64B
| $500K | 2.36% | 39,496 -34,384 | -47% | -$435K |
|
20
AbbVie
ABBV
$372B
| $425K | 2.01% | +2,391 | New | +$425K |
|
|
GRAL
21
GRAIL, Inc. Common Stock
GRAL
$1.18B
| $398K | 1.88% | 22,287 -11,110 | -33% | -$198K |
|
|
CKPT
22
DELISTED
Checkpoint Therapeutics
CKPT
| $395K | 1.87% | 123,475 -26,395 | -18% | -$84.5K |
|
|
FTHY
23
First Trust High Yield Opportunities 2027 Term Fund
FTHY
$539M
| $388K | 1.83% | +26,770 | New | +$388K |
|
24
Axon Enterprise
AXON
$58.7B
| $386K | 1.83% | +650 | New | +$386K |
|
25
Alphabet (Google) Class C
GOOG
$2.58T
| $386K | 1.83% | 2,027 -157 | -7% | -$29.9K |
|